![Miki Ben-Dor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Miki Ben-Dor
Chairman at Rimonyx Pharmaceuticals Ltd.
Profile
Miki Ben-Dor is currently the Chairman at Rimonyx Pharmaceuticals Ltd.
Prior to this, he held the position of Vice President at Discount Investment Corp.
Ltd.
and Vice President-Business Development at Tadiran Ltd.
He obtained an MBA from INSEAD.
Miki Ben-Dor active positions
Companies | Position | Start |
---|---|---|
Rimonyx Pharmaceuticals Ltd.
![]() Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Chairman | - |
Former positions of Miki Ben-Dor
Companies | Position | End |
---|---|---|
Tadiran Ltd.
![]() Tadiran Ltd. Telecommunications EquipmentElectronic Technology Part of Koor Industries Ltd., Tadiran Ltd. is an Israeli company that provides telecommunications, electronics, chemicals, food, and building materials. The company is based in Tel Aviv, Israel. | Corporate Officer/Principal | - |
DISCOUNT INVESTMENT CORPORATION LTD. | Corporate Officer/Principal | - |
Training of Miki Ben-Dor
INSEAD | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
DISCOUNT INVESTMENT CORPORATION LTD. | Retail Trade |
Private companies | 2 |
---|---|
Rimonyx Pharmaceuticals Ltd.
![]() Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
Tadiran Ltd.
![]() Tadiran Ltd. Telecommunications EquipmentElectronic Technology Part of Koor Industries Ltd., Tadiran Ltd. is an Israeli company that provides telecommunications, electronics, chemicals, food, and building materials. The company is based in Tel Aviv, Israel. | Electronic Technology |
- Stock Market
- Insiders
- Miki Ben-Dor